gsk glp 1 GlaxoSmithKline GLP-1 Tanzeum meets its end, and it doesn't bode well for Sanofi, AstraZeneca: analyst GLP-1 and Anesthesia: Considerations and

In SURPASS-AP trial insulin-naive diabetic patients not adequately controlled on therapy with metformin (with or without a sulphonylurea) in Australia, India, China and South Korea, were randomized to TZP 5 mg, 10 mg or 15 mg or insulin glargine

From an industry standpoint, this is also an opportunity to strengthen collaboration between pharma companies, clinicians, and regulators to build a more proactive adverse-event reporting culture in India

But the real problem is that theyre carrying extra weight

What role does diet play in preventing Ozempic face

This type of diabetes is connected with insulin resistance

Its not a commitment